Page 84 - AN-1-2

Advanced Neurology NMDA receptors in neuropsychiatric diseases

in Krushinskii-Molodkina strain rats with the inherited 291. Kiefer RT, Rohr P, Ploppa A, et al., 2008, Efficacy of ketamine
predisposition to audiogenic convulsions. Ross Fiziol Zh Im in anesthetic dosage for the treatment of refractory complex
I M Sechenova, 95: 802–812. regional pain syndrome: An open-label phase II study. Pain
Med, 9: 1173–1201.
281. Frey HH, Voits M, 1991, Effect of psychotropic agents on
a model of absence epilepsy in rats. Neuropharmacology, https://doi.org/1111/j.1526-4637.2007.00402.x
30: 651–656.
292. Duale C, Sibaud F, Guastella V, et al., 2009, Perioperative
https://doi.org/1016/0028-3908(91)90086-q ketamine does not prevent chronic pain after thoracotomy.
Eur J Pain, 13: 497–505.
282. Czuczwar SJ, Turski WA, Kleinrok Z, 1996, Interactions
of excitatory amino acid antagonists with conventional https://doi.org/1016/j.ejpain.2008.06.013
antiepileptic drugs. Metab Brain Dis, 11: 143–152.
293. Pud D, Eisenberg E, Spitzer A, et al., 1998, The NMDA
https://doi.org/1007/BF02069501 receptor antagonist amantadine reduces surgical
neuropathic pain in cancer patients: A double blind,
283. Wu LJ, Zhuo M, 2009, Targeting the NMDA receptor
subunit NR2B for the treatment of neuropathic pain. randomized, placebo controlled trial. Pain, 75: 349–354.
Neurotherapeutics, 6: 693–702. https://doi.org/1016/s0304-3959(98)00014-1
https://doi.org/1016/j.nurt.2009.07.008 294. Fukui S, Komoda Y, Nosaka S, 2001, Clinical application of
amantadine, an NMDA antagonist, for neuropathic pain.
284. Woolf CJ, Salter MW, Neuronal plasticity: increasing the
gain in pain. Science, 288: 1765–1769. J Anesth, 15: 179–181.
https://doi.org/1007/s005400170025
https://doi.org/1126/science.288.5472.1765
295. Lancaster CL, Teeters JB, Gros DF, et al., 2016, Posttraumatic
285. Isaev D, Gerber G, Park SK, et al., 2000, Facilitation of
NMDA-induced currents and Ca transients in the rat stress disorder: Overview of evidence-based assessment and
2+
substantia gelatinosa neurons after ligation of L5-L6 spinal treatment. J Clin Med, 5: 105.
nerves. Neuroreport, 11: 4055–4061. https://doi.org/3390/jcm5110105
https://doi.org/1097/00001756-200012180-00030 296. Gates MA, Holowka DW, Vasterling JJ, et al., 2012,
Posttraumatic stress disorder in veterans and military
286. Ultenius C, Linderoth B, Meyerson BA, et al., 2006, Spinal
NMDA receptor phosphorylation correlates with the personnel: Epidemiology, screening, and case recognition.
presence of neuropathic signs following peripheral nerve Psychol Serv, 9: 361–382.
injury in the rat. Neurosci Lett, 399: 85–90. https://doi.org/1037/a0027649
https://doi.org/1016/j.neulet.2006.01.018 297. Yuan K, Gong YM, Liu L, et al., Prevalence of posttraumatic
stress disorder after infectious disease pandemics in the
287. Gao X, Kim HK, Chung JM, et al., 2005, Enhancement of
NMDA receptor phosphorylation of the spinal dorsal horn twenty-first century, including COVID-19: A meta-analysis
and nucleus gracilis neurons in neuropathic rats. Pain, and systematic review. Mol Psychiatry, 26: 4982–4998.
116: 62–72. https://doi.org/1038/s41380-021-01036-x
https://doi.org/1016/j.pain.2005.03.045 298. Sofuoglu M, Rosenheck R, Petrakis I, 2014, Pharmacological
treatment of comorbid PTSD and substance use disorder:
288. Suzuki R, Matthews EA, Dickenson AH, 2001, Comparison
of the effects of MK-801, ketamine and memantine on Recent progress. Addict Behav, 39: 428–433.
responses of spinal dorsal horn neurones in a rat model of https://doi.org/1016/j.addbeh.2013.08.014
mononeuropathy. Pain, 91: 101–109.
299. Bestha D, Soliman L, Blankenship K, et al., 2018, The
https://doi.org/1016/s0304-3959(00)00423-1 walking wounded: Emerging treatments for PTSD. Curr
Psychiatry Rep, 20: 94.
289. Iwata H, Takasusuki T, Yamaguchi S, et al., 2007, NMDA
receptor 2B subunit-mediated synaptic transmission in https://doi.org/1007/s11920-018-0941-8
the superficial dorsal horn of peripheral nerve-injured 300. Krystal JH, Abdallah CG, Averill LA, et al., 2017, Synaptic
neuropathic mice. Brain Res, 1135: 92–101.
loss and the pathophysiology of PTSD: Implications for
https://doi.org/1016/j.brainres.2006.12.014 ketamine as a prototype novel therapeutic. Curr Psychiatry
Rep, 19: 74.
290. Correll GE, Maleki J, Gracely EJ, et al., 2004, Subanesthetic
ketamine infusion therapy: A retrospective analysis of https://doi.org/1007/s11920-017-0829-z
a novel therapeutic approach to complex regional pain 301. Feder A, Parides MK, Murrough JW, et al. Efficacy
syndrome. Pain Med, 5: 263–275.
of intravenous ketamine for treatment of chronic
https://doi.org/1111/j.1526-4637.2004.04043.x. posttraumatic stress disorder: A randomized clinical trial.

Volume 1 Issue 2 (2022) 28 https://doi.org/10.36922/an.v1i2.148